Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety reportAlicia Okines, David Cunningham, Ruth E. Langley et al.|Annals of Oncology|2012Cited by 67
Calbindin 2 (CALB2) Regulates 5-Fluorouracil Sensitivity in Colorectal Cancer by Modulating the Intrinsic Apoptotic PathwayLeanne Stevenson, Patrick G. Johnston|PLoS ONE|2011Cited by 49
2201 Peri-operative chemotherapy ± bevacizumab for resectable gastro-oesophageal adenocarcinoma: Results from the UK Medical Research Council randomised ST03 trial (ISRCTN 46020948)David Cunningham, R. Langley, E. Smyth et al.|European Journal of Cancer|2015Cited by 31
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinomaRichard Turkington, Richard D. Kennedy, Damian McManus et al.|Gut|2019Cited by 27